Boehringer Ingelheim

Startseite
Deutschland
Ingelheim am Rhein
Boehringer Ingelheim

Driving healthcare innovation for people and animals.
Welcome to our Facebook channel. g.

We are a German research-driven pharmaceutical company and it’s our goal to improve the lives of humans and animals worldwide. Country-specific content may have been issued in the countries where we do business. Follow us for news about healthcare topics, our research & development and company updates. This is a place where you can share your thoughts, and connect with other people. We are looking forward to exchanging ideas and engaging in conversations! We want to ensure that this is a safe and informative environment and respectfully request that you follow our Community Guidelines:

• Be nice to each other, even if you disagree

• Be constructive and inspire further conversations

• Please do not provide diagnoses or treatment advice

• We don’t tolerate discriminatory or derogatory comments, hate speech, especially humiliation of people or groups of people

• We don’t tolerate threats and requests for violence against anyone or anything

• We don’t tolerate po*******hy, profanity, and other content that puts young people at risk

• Please don’t infringe on the applicable legislation (e. on data protection), copyrights or trademarks

• The comment function should not be misused as advertising space or for other off-topic subjects

• We don’t tolerate the promotion of illegal activities

You acknowledge that you, not Boehringer Ingelheim, are responsible for the contents of your submission. We reserve ourselves the right to delete or hide any content on our social media pages that violate the Community Guidelines.

13/11/2025

Does your ferocious feline turn into a scaredy cat at the vet? Cats get stressed in unfamiliar situations so getting your cat used to transport can go a long way. Veterinarian and cat expert Dr. Teresa Baur-Rehme (Ludwig-Maximilians-Universität München) shares tips.

13/11/2025

Paper leaflets are hard to read, harder to fold back, and often end up in the trash without a second glance. But what if there was a smarter way?

💡Say hello to electronic product information (ePI) - a digital solution that could finally put an end to the paper chaos.

➡️ Discover how ePI is transforming the leaflet experience: go.boehringer.com/jT9Ay

11/11/2025

Extrapulmonary neuroendocrine carcinoma (epNEC) is an aggressive and often misdiagnosed type of cancer, occurring in multiple organs outside of the lung, including the breast, urogenital system, skin, head and neck.

By collaborating with dedicated patient organizations like Minkahz NETs Mission, we can advocate for greater awareness and resources for those affected – driving meaningful change.

Learn more about epNEC and the ongoing efforts to improve outcomes for patients: https://go.boehringer.com/YPy9_

09/11/2025

The impact biomarkers have on cancer care is profound.

In non-small cell lung cancer (NSCLC), one of them is known as HER2 mutations, and it can greatly affect how the disease progresses and behaves. Identifying these mutations is crucial for creating personalized cancer care plans.

Learn more about the role of biomarker testing: https://go.boehringer.com/SNNWs

05/11/2025

Biomarkers – like gene mutations, proteins, or other substances - are crucial in managing non-small cell lung cancer (NSCLC). For instance, HER2 mutations, present in some NSCLC cases, can lead to rapid cancer growth, influencing care decisions and outcomes.
By understanding biomarkers, oncologists can tailor cancer care to suit individual patients' needs.

Explore how these genetic insights are transforming lung cancer care: https://go.boehringer.com/IktE

05/11/2025

Did you know that (CKD) is closely linked to cardiovascular disease (CVD)?

CKD often has no symptoms in its early stages, but if left undetected it can affect other important organs – like your heart.

If you have heart disease, you could be at risk. Early screening helps protect both your kidneys and your heart.

Know your risks. Learn more here: https://go.boehringer.com/URG76

03/11/2025

In lung cancer, the presence of specific biomarkers can be crucial for guiding informed healthcare decisions.

In some non-small cell lung cancer (NSCLC) cases, mutations in the HER2 gene can cause cells to grow uncontrollably, leading to cancer.

Identifying these biomarkers is crucial for determining the most effective cancer care path and improving outcomes.

Explore how biomarker testing in lung cancer can make a real difference: https://go.boehringer.com/2USzw

30/10/2025

What does a chicken farm in Argentina have to do with your health? Everything.

Through our collaboration with the Andar Farm, we're educating the next generation of vets and farmers on sustainable and safe farming practises to limit the spread of disease.

Everything is connected, and protecting animal health means we're protecting human health too.

Find out more here: https://go.boehringer.com/k1hA8

23/10/2025

Your kidneys and heart work together as part of an interconnected system.

When your kidneys don’t work properly, it can place extra stress on the heart. That’s why people living with have a higher risk of cardiovascular complications, like heart failure.

By preserving your kidneys, you are protecting your heart too.

If you have type 2 diabetes, high blood pressure or cardiovascular disease, talk to your doctor about screening today ❤️

23/10/2025

For people living with bronchiectasis, symptoms like chest pain and breathlessness can affect everyday life - even when they aren’t always visible to others.

Frank’s story highlights why understanding symptoms matters in care

Hear his full story and learn more below 👇

20/10/2025

Cancer is one of today’s greatest challenges, and it is the experience and resilience of those living with that inspires our commitment to advance oncology research and explore innovation in critical areas.

Our work explores a range of scientific approaches, including novel targeted research areas, designed to address the biggest unmet needs and significantly impact patients.

Learn more about our mission to support progress in oncology: https://go.boehringer.com/HHxkY

18/10/2025

Each person’s lung cancer is unique and can be driven by genetic mutations, known as biomarkers. Testing for these can provide important insights into the biology of non-small cell lung cancer (NSCLC), supporting the advancement of personalized approaches to cancer care.

Early testing can offer healthcare teams valuable information about the cancer’s specific characteristics.

Learn more: https://go.boehringer.com/kySKI

Adresse

Boehringer Ingelheim GmbH, Binger Straße 173
Ingelheim Am Rhein
55216

Telefon

+496132770

Webseite

http://www.boehringer-ingelheim.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Boehringer Ingelheim erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.